RVNC stock forecast for 2023 – 2027
Last updated: April 25, 2024
Are you interested in Revance Therapeutics, Inc. stocks prediction? If yes, then on this page you will find useful information about the dynamics of the RVNC stock price in 2022-2027. Is RVNC a good long term stock? When should I take profit in Revance Therapeutics stock? Buy or sell stock? Will RVNC stock price go up? What are analysts’ forecasts for RVNC stock?
Forecst.com predicts future values using technical analysis of a large number of analytical parameters. RVNC stock returns are also predicted based on historical data.
According to our research, RVNC stock is a not so good long-term investment. RVNC share price has been in a bull cycle for the past year. Revance Therapeutics, Inc. stock trend is positive.
Revance Therapeutics company info
| Industry | Biotechnology |
| Address | 1222 Demonbreun Street, Newark, CA, 37203, United States |
| Website | https://www.revance.com |
Forecasting
52 Week High: 16.0766 USD
52 Week Low: 12.175 USD
1 Year Forecast: 13.559 USD
5 Year Forecast: 15.1831 USD
Agilent Technologies info
Market Cap: 971.38M
52 Week Change: -14.722%
52 Week High: 33.83 USD
52 Week Low: 11.84 USD
Beta: 1.10637
50 Day Moving Average: 15.37
90 Day Moving Average: 14.881
200 Day Moving Average: 20.83
Resistance Level: 13.9131
Pivot Point: 13.2591
Support Level: 12.727
Enterprise Value: 0
Forward P/E: 0
Forward EPS: 0
Profit Margin: 0
Shares Outstanding: 0
EBITDA: 0
Held Percent Institutions: 0
PEG Ratio (5Y): 0
Trailing EPS: 0
Revance Therapeutics stock forecasts for 2023-2027
| Date | Open Price | Close Price | Change |
Revance Therapeutics Stock Forecast for 2023 | |||
| January 2023 | 14.28 | 13.13 | -8.05% |
| February 2023 | 13.13 | 13.72 | 4.49% |
| March 2023 | 13.86 | 13.13 | -5.27% |
| April 2023 | 12.87 | 13.86 | 7.69% |
| May 2023 | 14.14 | 15.15 | 7.14% |
| June 2023 | 14.85 | 15.84 | 6.67% |
| July 2023 | 15.68 | 15.15 | -3.38% |
| August 2023 | 14.85 | 14.14 | -4.78% |
| September 2023 | 14.28 | 14.14 | -0.98% |
| October 2023 | 13.72 | 13.26 | -3.35% |
| November 2023 | 13 | 14.14 | 8.77% |
| December 2023 | 13 | 15.15 | 16.54% |
Revance Therapeutics Stock Forecast for 2024 | |||
| January 2024 | 15.3 | 14 | -8.5% |
| February 2024 | 14 | 14 | 0% |
| March 2024 | 14.28 | 13.13 | -8.05% |
| April 2024 | 13.13 | 13.72 | 4.49% |
| May 2024 | 14.14 | 15.15 | 7.14% |
| June 2024 | 16.16 | 17.34 | 7.3% |
| July 2024 | 17.34 | 15.3 | -11.76% |
| August 2024 | 15.3 | 13.72 | -10.33% |
| September 2024 | 14.85 | 14.7 | -1.01% |
| October 2024 | 13.86 | 13 | -6.2% |
| November 2024 | 12.87 | 14.14 | 9.87% |
| December 2024 | 14 | 15.3 | 9.29% |
Revance Therapeutics Stock Forecast for 2025 | |||
| January 2025 | 15.3 | 14.14 | -7.58% |
| February 2025 | 14.28 | 15.3 | 7.14% |
| March 2025 | 14.7 | 13.72 | -6.67% |
| April 2025 | 14.28 | 14.7 | 2.94% |
| May 2025 | 15.3 | 16.16 | 5.62% |
| June 2025 | 15.84 | 16.83 | 6.25% |
| July 2025 | 16.66 | 16.32 | -2.04% |
| August 2025 | 15.68 | 15 | -4.34% |
| September 2025 | 15.3 | 15 | -1.96% |
| October 2025 | 14.7 | 13.86 | -5.71% |
| November 2025 | 14.28 | 13.86 | -2.94% |
| December 2025 | 14.28 | 16.32 | 14.29% |
Revance Therapeutics Stock Forecast for 2026 | |||
| January 2026 | 16.32 | 14.7 | -9.93% |
| February 2026 | 15.15 | 15.15 | 0% |
| March 2026 | 15.15 | 15.15 | 0% |
| April 2026 | 14.7 | 14.7 | 0% |
| May 2026 | 15.3 | 16.16 | 5.62% |
| June 2026 | 16 | 18 | 12.5% |
| July 2026 | 18.36 | 16 | -12.85% |
| August 2026 | 15.68 | 14.7 | -6.25% |
| September 2026 | 16.16 | 15.84 | -1.98% |
| October 2026 | 15.84 | 13.86 | -12.5% |
| November 2026 | 14 | 15.3 | 9.29% |
| December 2026 | 15 | 17.17 | 14.47% |
Revance Therapeutics Stock Forecast for 2027 | |||
| January 2027 | 16 | 14.7 | -8.13% |